General Biotechnology

Gene Doping Threatens to Transform Sports “If it does take off, sport as we know it will disappear”

FDA Acts To Speed Bioterror Medicines Responding to the threat of anthrax and other forms of chemical and biological terrorism,

A Challenge to Science and Nature A new journal will challenge publishing behemoths such as Science, Nature and Cell by

Life after Venter At Celera Genomics, a new president and questions about the company’s direction.

Biotech heads west for VC The pot of gold to fund biotech research in Memphis may come from Little Rock

Cloning Bill Bans Abortion Too? Cloning and abortion — separate issues altogether, right? Maybe not. There are those who believe

Biotech Banker Predicts More Meetings But Fewer Attendees It’s tougher and tougher for people to figure out what’s the right

Faulty Genes Explain Why Cloning Is So Difficult Cloning may not always completely reprogram an egg cell the way sexual

Two New Bills Present Challenges to DNA Patentability This time the challenge to the patents, commonly called gene patents, comes

Biotech industry’s still waiting to break out It turns out that even with the genome in hand, discovering drugs and